Awaiting product image

Article: Three-year follow-up data of ELOQUENT-2: sustained benefit of elotuzumab in patients with relapsed/ refractory multiple myeloma

€2.42

SKU: product-article-17987 Category:

Description

Three-year follow-up data of ELOQUENT-2: sustained benefit of elotuzumab in patients with relapsed/ refractory multiple myeloma

Reviews

There are no reviews yet.

Be the first to review “Article: Three-year follow-up data of ELOQUENT-2: sustained benefit of elotuzumab in patients with relapsed/ refractory multiple myeloma”

Your email address will not be published. Required fields are marked *

Related products